Eyenuk, Inc.

Eyenuk, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Eyenuk, Inc. is a global artificial intelligence (AI) medical technology and services company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk’s first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk and Alzheimer’s disease.
Looking for a particular Eyenuk, Inc. employee's phone or email?

Eyenuk, Inc. Questions

News

Eyenuk Secures World’s First National Health System Deployment of Autonomous AI Eye Screening Technology - GlobeNewswire

Eyenuk Secures World’s First National Health System Deployment of Autonomous AI Eye Screening Technology GlobeNewswire

Eyenuk Appoints Gaurav Agarwal as Chief Executive Officer and Mads Dall as Chairman of the Board - citybiz

Eyenuk Appoints Gaurav Agarwal as Chief Executive Officer and Mads Dall as Chairman of the Board citybiz

Eyenuk Announces FDA Clearance for EyeArt Autonomous AI System for Diabetic Retinopathy Screening - Business Wire

Eyenuk Announces FDA Clearance for EyeArt Autonomous AI System for Diabetic Retinopathy Screening Business Wire

New FDA Clearance Makes Eyenuk the First Company with Multiple Cameras for Autonomous AI Detection of Diabetic Retinopathy - PR Newswire

New FDA Clearance Makes Eyenuk the First Company with Multiple Cameras for Autonomous AI Detection of Diabetic Retinopathy PR Newswire

Study: Eyenuk artificial intelligence detects diabetic retinopathy with more sensitivity than dilated exams - Ophthalmology Times

Study: Eyenuk artificial intelligence detects diabetic retinopathy with more sensitivity than dilated exams Ophthalmology Times

Eyenuk hits bull's-eye with $26M for diabetic retinopathy screening AI - Fierce Biotech

Eyenuk hits bull's-eye with $26M for diabetic retinopathy screening AI Fierce Biotech

AI-powered eye screening platform Eyenuk raises $25M - Mobi Health News

AI-powered eye screening platform Eyenuk raises $25M Mobi Health News

Eyenuk, a global provider of AI-powered eye screenings, scores $26M to expand reach in 18 countries - Fierce Healthcare

Eyenuk, a global provider of AI-powered eye screenings, scores $26M to expand reach in 18 countries Fierce Healthcare

Norway is first in world to deploy autonomous AI eye screening technology on national scale - Optometry Times

Norway is first in world to deploy autonomous AI eye screening technology on national scale Optometry Times

Eyenuk Appoints Bryan Haardt as Chief Executive Officer - BioSpace

Eyenuk Appoints Bryan Haardt as Chief Executive Officer BioSpace

Eyenuk Appoints Bryan Haardt as Chief Executive Officer - VisionMonday.com

Eyenuk Appoints Bryan Haardt as Chief Executive Officer VisionMonday.com

FDA clears use of Topcon retinal camera with EyeArt AI system for DR detection - Healio

FDA clears use of Topcon retinal camera with EyeArt AI system for DR detection Healio

Eyenuk receives FDA approval for EyeArt v2.2.0 system - Medical Device Network

Eyenuk receives FDA approval for EyeArt v2.2.0 system Medical Device Network

As AI Eye Exams Prove Their Worth, Lessons for Future Tech Emerge - KFF Health News

As AI Eye Exams Prove Their Worth, Lessons for Future Tech Emerge KFF Health News

Eyenuk secures $26 Million Series A funding to accelerate global access to AI-powered eye-screening technology - PR Newswire

Eyenuk secures $26 Million Series A funding to accelerate global access to AI-powered eye-screening technology PR Newswire

Eyenuk CEO and founder gives insight into FDA clearance of additional camera for EyeArt AI - Ophthalmology Times

Eyenuk CEO and founder gives insight into FDA clearance of additional camera for EyeArt AI Ophthalmology Times

EyeArt AI system approved in EU for detecting AMD, glaucomatous optic nerve damage - Healio

EyeArt AI system approved in EU for detecting AMD, glaucomatous optic nerve damage Healio

Eyenuk Teams with the American Academy of Ophthalmology to - GlobeNewswire

Eyenuk Teams with the American Academy of Ophthalmology to GlobeNewswire

Eyenuk Names Paul Praino Interim Chief Executive Officer - PR Newswire

Eyenuk Names Paul Praino Interim Chief Executive Officer PR Newswire

How AI Is Detecting Diabetic Retinopathy - Making Sense of Diabetes

How AI Is Detecting Diabetic Retinopathy Making Sense of Diabetes

EyeArt Autonomous AI System Cleared for Diabetic Retinopathy Screening - Medical Professionals Reference

EyeArt Autonomous AI System Cleared for Diabetic Retinopathy Screening Medical Professionals Reference

Autonomous diabetic retinopathy screening system gains FDA approval - American Academy of Ophthalmology

Autonomous diabetic retinopathy screening system gains FDA approval American Academy of Ophthalmology

Eyenuk Launches EyeScreen Human + AI Diagnostic Service - VisionMonday.com

Eyenuk Launches EyeScreen Human + AI Diagnostic Service VisionMonday.com

EyeArt: Automated, High-throughput, Image Analysis for Diabetic Retinopathy Screening - ARVO Journals

EyeArt: Automated, High-throughput, Image Analysis for Diabetic Retinopathy Screening ARVO Journals

Indigenously Developed Smartphone-based Retinal Imaging Device Powers Automated, Sensitive and Early Detection of Diabetic Retinopathy: Study in Nature Eye Journal - PR Newswire

Indigenously Developed Smartphone-based Retinal Imaging Device Powers Automated, Sensitive and Early Detection of Diabetic Retinopathy: Study in Nature Eye Journal PR Newswire

Diabetic Retinopathy is Preventable Vision Loss with These Latest Tools and Treatments - InvisionMag.com

Diabetic Retinopathy is Preventable Vision Loss with These Latest Tools and Treatments InvisionMag.com

Global Digital Biomarkers Market Set to Grow at ~17% CAGR by 2032 | DelveInsight - The Globe and Mail

Global Digital Biomarkers Market Set to Grow at ~17% CAGR by 2032 | DelveInsight The Globe and Mail

Top Eyenuk, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant